Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker |
| |
| Authors: | Rui Zhang Wei Wang Nie Zhang Xueting Chen Wanming Liu Longzhen Zhang Nianli Liu |
| |
| Affiliation: | 1. Cancer Institute, Xuzhou Medical University, Xuzhou China ; 2. Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou China ; 3. Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou China |
| |
| Abstract: | ![]()
|
| |
| Keywords: | cancer immunology, immunological biomarker, pan‐ cancer, prognostic marker, RBM39 |
|
|
